Bethyl Laboratories
Human IL-5 ELISA KitNew
ELISA Kits
Catalog #E82-011
TargetHuman IL-5
ReactivityHuman
ApplicationELISA
Image 1 of 1
local_shipping
Please allow 3-5 business days for shipment.
Product Description
IL-5 is a homodimeric cytokine expressed predominantly by T-lymphocytes and NK cells that plays an important role in the survival, differentiation, and chemotaxis of eosinophils. IL-5 also acts on activated and resting B-cells to induce immunoglobulin production, growth, and differentiation. IL-5 exerts its biological effects through a receptor composed of IL5RA subunit and the cytokine receptor common subunit beta/CSF2RB. Binding to the receptor leads to activation of various kinases including LYN, SYK and JAK2 and thereby propagates signals through the RAS-MAPK and JAK-STAT5 pathways respectively [taken from the Universal Protein Resource (UniProt) www.uniprot.org/uniprot/P05113].
Specifications
Reactivity
Human
Target Identity
TargetHuman IL-5
Gene ID3567
Gene Symbol
IL5
Gene Name
interleukin 5
Uniprot IDP05113
Protein Name
Interleukin-5
Product Information
Applications
ELISA
Assay Type
Sandwich ELISA
Assay Range
2.74 pg/ml - 2000 pg/ml
Sample Type
Serum, Plasma, & Cell Culture Supernatant
Detection Method
Biotinylated-Streptavidin-HRP
Storage Conditions
2 - 8 °C
Shelf Life
6 months from date of receipt
Contents
- Human IL-5 Pre-Coated 96-well Strip Plate, 1 each
- Human IL-5 Standard vial, 2 each
- Human IL-5 Detection Antibody
- Assay Diluent(s)
- Streptavidin-HRP Solution, 200µl
- TMB Substrate, 12 ml
- Stop Solution, 12 ml
- 20X Wash Buffer, 25 ml
- Sealing Tape, 2 sheets
Country of Origin
USA
Documents
Safety Data SheetPDF · E82-011Open
Product DatasheetPDF · E82-011Open
Services
Antibody Conjugation
Antibody and conjugate formats developed together, built to your specification.
Request CustomizationCustom Monoclonal Antibody Discovery Services
Full custom monoclonal development, from immunization through validation.
Explore Monoclonal DevelopmentVHH Discovery
Single-domain antibodies for structurally difficult targets a conventional monoclonal can't reach.
Explore VHH DiscoveryResources
1



